Free Trial

Protara Therapeutics (TARA) SEC Filings & 10K Form

Protara Therapeutics logo
$3.19 -0.07 (-2.15%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$3.25 +0.06 (+1.88%)
As of 08/14/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Protara Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2025
5:03 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
08/14/2025
10:15 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
08/11/2025
4:09 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/11/2025
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
7:11 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2025
6:54 PM
BlackRock, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
07/07/2025
3:10 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
3:10 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
CONKLING WILLIAM (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2025
11:13 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
05/12/2025
8:01 AM
Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
7:47 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B7
04/28/2025
7:35 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
3:05 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
3:10 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
10:17 AM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Zummo Jacqueline (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
11:58 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
03/05/2025
7:07 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:16 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:40 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:24 PM
CITADEL ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:23 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
5:31 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:30 AM
Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:34 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:20 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
Form SC 13G
12/11/2024
3:19 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
6:30 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/09/2024
3:17 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/05/2024
7:45 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:01 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G
11/14/2024
11:19 AM
CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G/A
$100 Trillion “AI Metal” Found in American Ghost Town (Ad)

Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.

Click here to get the details on this virtual monopoly.
09/12/2024
7:20 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:11 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TARA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners